142 related articles for article (PubMed ID: 32970506)
1. Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategies.
Pegoraro S; Ros G; Sgubin M; Petrosino S; Zambelli A; Sgarra R; Manfioletti G
Expert Opin Ther Targets; 2020 Oct; 24(10):953-969. PubMed ID: 32970506
[TBL] [Abstract][Full Text] [Related]
2. High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression.
Sgarra R; Pegoraro S; Ros G; Penzo C; Chiefari E; Foti D; Brunetti A; Manfioletti G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):216-229. PubMed ID: 29518471
[TBL] [Abstract][Full Text] [Related]
3. Conformational role for the C-terminal tail of the intrinsically disordered high mobility group A (HMGA) chromatin factors.
Maurizio E; Cravello L; Brady L; Spolaore B; Arnoldo L; Giancotti V; Manfioletti G; Sgarra R
J Proteome Res; 2011 Jul; 10(7):3283-91. PubMed ID: 21545188
[TBL] [Abstract][Full Text] [Related]
4. High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network.
Sgarra R; Pegoraro S; D'Angelo D; Ros G; Zanin R; Sgubin M; Petrosino S; Battista S; Manfioletti G
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979076
[TBL] [Abstract][Full Text] [Related]
5. HMGA molecular network: From transcriptional regulation to chromatin remodeling.
Sgarra R; Zammitti S; Lo Sardo A; Maurizio E; Arnoldo L; Pegoraro S; Giancotti V; Manfioletti G
Biochim Biophys Acta; 2010; 1799(1-2):37-47. PubMed ID: 19732855
[TBL] [Abstract][Full Text] [Related]
6. HMGA and Cancer: A Review on Patent Literatures.
De Martino M; Fusco A; Esposito F
Recent Pat Anticancer Drug Discov; 2019; 14(3):258-267. PubMed ID: 31538905
[TBL] [Abstract][Full Text] [Related]
7. HMGA and cancer.
Fedele M; Fusco A
Biochim Biophys Acta; 2010; 1799(1-2):48-54. PubMed ID: 20123067
[TBL] [Abstract][Full Text] [Related]
8. Critical role of HMGA proteins in cancer cell chemoresistance.
D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
[TBL] [Abstract][Full Text] [Related]
9. Discovering high mobility group A molecular partners in tumour cells.
Sgarra R; Tessari MA; Di Bernardo J; Rustighi A; Zago P; Liberatori S; Armini A; Bini L; Giancotti V; Manfioletti G
Proteomics; 2005 Apr; 5(6):1494-506. PubMed ID: 15798993
[TBL] [Abstract][Full Text] [Related]
10. Roles of HMGA proteins in cancer.
Fusco A; Fedele M
Nat Rev Cancer; 2007 Dec; 7(12):899-910. PubMed ID: 18004397
[TBL] [Abstract][Full Text] [Related]
11. Arabidopsis chromatin-associated HMGA and HMGB use different nuclear targeting signals and display highly dynamic localization within the nucleus.
Launholt D; Merkle T; Houben A; Schulz A; Grasser KD
Plant Cell; 2006 Nov; 18(11):2904-18. PubMed ID: 17114349
[TBL] [Abstract][Full Text] [Related]
12. The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin.
D'Angelo D; Borbone E; Palmieri D; Uboldi S; Esposito F; Frapolli R; Pacelli R; D'Incalci M; Fusco A
Eur J Cancer; 2013 Mar; 49(5):1142-51. PubMed ID: 23149213
[TBL] [Abstract][Full Text] [Related]
13. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
[TBL] [Abstract][Full Text] [Related]
14. Interplay between HMGA and TP53 in cell cycle control along tumor progression.
Meireles Da Costa N; Palumbo A; De Martino M; Fusco A; Ribeiro Pinto LF; Nasciutti LE
Cell Mol Life Sci; 2021 Feb; 78(3):817-831. PubMed ID: 32920697
[TBL] [Abstract][Full Text] [Related]
15. HMGA proteins as therapeutic drug targets.
Reeves R; Beckerbauer LM
Prog Cell Cycle Res; 2003; 5():279-86. PubMed ID: 14593722
[TBL] [Abstract][Full Text] [Related]
16. [HMGA proteins and their genes as a potential neoplastic biomarkers].
Balcerczak E; Balcerczak M; Mirowski M
Postepy Biochem; 2005; 51(3):261-9. PubMed ID: 16381170
[TBL] [Abstract][Full Text] [Related]
17. Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification.
Guestini F; McNamara KM; Ishida T; Sasano H
Expert Opin Ther Targets; 2016 Jun; 20(6):705-20. PubMed ID: 26607563
[TBL] [Abstract][Full Text] [Related]
18. HMGA Proteins in Stemness and Differentiation of Embryonic and Adult Stem Cells.
Parisi S; Piscitelli S; Passaro F; Russo T
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935816
[TBL] [Abstract][Full Text] [Related]
19. Selection of Natural Compounds with HMGA-Interfering Activities and Cancer Cell Cytotoxicity.
Mori M; Ghirga F; Amato B; Secco L; Quaglio D; Romeo I; Gambirasi M; Bergamo A; Covaceuszach S; Sgarra R; Botta B; Manfioletti G
ACS Omega; 2023 Sep; 8(36):32424-32431. PubMed ID: 37720761
[TBL] [Abstract][Full Text] [Related]
20. Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties.
Sgarra R; Maurizio E; Zammitti S; Lo Sardo A; Giancotti V; Manfioletti G
J Proteome Res; 2009 Jun; 8(6):2978-89. PubMed ID: 19317492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
